For HSP84, these figures were 3, 20 and 2, respectively, in the 25 mixed tumor cases; 7, 6 and 0, respectively, in the 13 adenolymphoma cases; and 2, 1 and 0 in the three other benign tumor cases (P<0.05). This evidence concerns the gene HSP90AB1 and Warthin tumor.